Kepos Capital’s Inspire Medical Systems INSP Stock Holding History

Kepos Capital’s Portfolio INSP Stock Details INSP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-5,987	Closed	-$340K	–	357
2019 Q1	$340K	Buy	+5,987	New	+$323K	0.03%	296

Other funds holding INSP

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

CCI

Columbus Circle Investors $2.28B AUM 135.57% 1-Year Est. Return

Kepos Capital's INSP Position: Q2 2019 in Review

Kepos Capital sold out of Inspire Medical Systems (INSP) in Q2 2019, closing a stake of 5,987 shares — an estimated $340K sold.

Kepos Capital first reported a position in INSP in Q1 2019 and held it in 1 quarter. The position peaked at $340K in Q1 2019. 148 funds tracked by Wall St. Rank hold INSP as of Q2 2019.

Kepos Capital reported no remaining Inspire Medical Systems position as of Q2 2019 after selling out during the quarter.
Kepos Capital sold 5,987 Inspire Medical Systems shares in Q2 2019, an estimated $340K.
Kepos Capital first reported a position in Inspire Medical Systems in Q1 2019 and held it in 1 quarter.
Kepos Capital's Inspire Medical Systems position peaked at $340K in Q1 2019.
148 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q2 2019.

Based on Kepos Capital's 13F filing for Q2 2019, filed 13 Aug 2019.